Construction of JinMeds New Facility Begins in Chuzhou, China
| ZJYL Stock | 0.91 0.07 7.14% |
About 62% of JIN MEDICAL's investor base is looking to short. The analysis of overall sentiment of trading JIN MEDICAL INTERNATIONAL stock suggests that many investors are alarmed at this time. JIN MEDICAL's investing sentiment shows overall attitude of investors towards JIN MEDICAL INTERNATIONAL.
JIN |
Chuzhou City, China, Oct. 10, 2024 -- JIN MEDICAL INTERNATIONAL LTD. , an industrial leader in Assistive Technologies , and a manufacturer and developer of wheelchairs and living aids products, today announced the initiation of construction of JinMeds new manufacturing facility at Chuzhou City, Anhui Province, China. JinMed Co., Ltd., a newly established subsidiary of JinMed, will be designated to operate the Chuzhou JinMe
Read at finance.yahoo.com
 |
JIN MEDICAL Fundamental Analysis
We analyze JIN MEDICAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JIN MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JIN MEDICAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
JIN MEDICAL is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
JIN MEDICAL INTERNATIONAL Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with JIN MEDICAL stock to make a market-neutral strategy. Peer analysis of JIN MEDICAL could also be used in its relative valuation, which is a method of valuing JIN MEDICAL by comparing valuation metrics with similar companies.
Peers
JIN MEDICAL Related Equities
| RYAAY | Ryanair Holdings | 0.41 | ||||
| SNCY | Sun Country | 0.21 | ||||
| LINC | Lincoln Educational | 0.36 | ||||
| UTI | Universal Technical | 0.65 | ||||
| AAL | American Airlines | 0.82 | ||||
| EDTK | Skillful Craftsman | 3.85 | ||||
| BEDU | Bright Scholar | 5.41 |
Check out JIN MEDICAL Hype Analysis, JIN MEDICAL Correlation and JIN MEDICAL Performance. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.